MRP ₹131
(Inclusive of all Taxes)
₹19.6 Cashback (15%)
%2520JP_OneCard.png?tr=q-85,f-webp,w-50,dpr-1,c-at_max){kind=small}
Extra 15% Off with Bank Offers
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
निर्माता/विपणक :
एलिकन फार्मास्युटिकल प्राइवेट लिमिटेड
सेवन का प्रकार :
मौखिक
वापसी नीति :
वापसी योग्य नहीं
इसके बाद या उसके बाद समाप्त होता है :
Jan-27
Have a query?
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Metosartan CH 50 mg/6.25 mg/40 mg Tablet:
Co-administration of Aliskiren with Metosartan CH 50 mg/6.25 mg/40 mg Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Metosartan CH 50 mg/6.25 mg/40 mg Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Co-administration of Aliskiren with Metosartan CH 50 mg/6.25 mg/40 mg Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Metosartan CH 50 mg/6.25 mg/40 mg Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Critical
How does the drug interact with Metosartan CH 50 mg/6.25 mg/40 mg Tablet:
Co-administration of Metosartan CH 50 mg/6.25 mg/40 mg Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Metosartan CH 50 mg/6.25 mg/40 mg Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
Co-administration of Metosartan CH 50 mg/6.25 mg/40 mg Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Metosartan CH 50 mg/6.25 mg/40 mg Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
TelmisartanPotassium citrate
Severe
How does the drug interact with Metosartan CH 50 mg/6.25 mg/40 mg Tablet:
Taking Potassium citrate with Metosartan CH 50 mg/6.25 mg/40 mg Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Metosartan CH 50 mg/6.25 mg/40 mg Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Taking Potassium citrate with Metosartan CH 50 mg/6.25 mg/40 mg Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Metosartan CH 50 mg/6.25 mg/40 mg Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Severe
How does the drug interact with Metosartan CH 50 mg/6.25 mg/40 mg Tablet:
Taking quinapril with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Metosartan CH 50 mg/6.25 mg/40 mg Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking quinapril with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Metosartan CH 50 mg/6.25 mg/40 mg Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Metosartan CH 50 mg/6.25 mg/40 mg Tablet:
Co-administration of amiloride with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm).
How to manage the interaction:
Although there is a possible interaction, amiloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
Co-administration of amiloride with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm).
How to manage the interaction:
Although there is a possible interaction, amiloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
How does the drug interact with Metosartan CH 50 mg/6.25 mg/40 mg Tablet:
Taking spironolactone with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is a possible interaction, Metosartan CH 50 mg/6.25 mg/40 mg Tablet can be taken with spironolactone if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking spironolactone with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is a possible interaction, Metosartan CH 50 mg/6.25 mg/40 mg Tablet can be taken with spironolactone if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Metosartan CH 50 mg/6.25 mg/40 mg Tablet:
Co-administration of Metosartan CH 50 mg/6.25 mg/40 mg Tablet may significantly increase the blood levels of lithium.
How to manage the interaction:
Although there is a possible interaction, Metosartan CH 50 mg/6.25 mg/40 mg Tablet can be taken with lithium if prescribed by the doctor. Consult the prescriber if you experience symptoms of lithium intoxication such as drowsiness, dizziness, confusion, loose stools, vomiting, muscle weakness, muscle incoordination, shaking of hands and legs, blurred vision, ringing in the ear, excessive thirst, or increased urination. Do not discontinue the medication without consulting a doctor.
Co-administration of Metosartan CH 50 mg/6.25 mg/40 mg Tablet may significantly increase the blood levels of lithium.
How to manage the interaction:
Although there is a possible interaction, Metosartan CH 50 mg/6.25 mg/40 mg Tablet can be taken with lithium if prescribed by the doctor. Consult the prescriber if you experience symptoms of lithium intoxication such as drowsiness, dizziness, confusion, loose stools, vomiting, muscle weakness, muscle incoordination, shaking of hands and legs, blurred vision, ringing in the ear, excessive thirst, or increased urination. Do not discontinue the medication without consulting a doctor.
Severe
How does the drug interact with Metosartan CH 50 mg/6.25 mg/40 mg Tablet:
Taking Metosartan CH 50 mg/6.25 mg/40 mg Tablet with benazepril may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Metosartan CH 50 mg/6.25 mg/40 mg Tablet can be taken with benazepril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medication without consulting a doctor.
Taking Metosartan CH 50 mg/6.25 mg/40 mg Tablet with benazepril may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Metosartan CH 50 mg/6.25 mg/40 mg Tablet can be taken with benazepril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medication without consulting a doctor.
Severe
How does the drug interact with Metosartan CH 50 mg/6.25 mg/40 mg Tablet:
Coadministration of enalapril with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Coadministration of enalapril with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Severe
How does the drug interact with Metosartan CH 50 mg/6.25 mg/40 mg Tablet:
Taking trimethoprim with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is an interaction between Metosartan CH 50 mg/6.25 mg/40 mg Tablet and trimethoprim, they can be taken together if prescribed by a doctor. However, consult a doctor if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, and a weak pulse. Do not discontinue the medications without consulting a doctor.
Taking trimethoprim with Metosartan CH 50 mg/6.25 mg/40 mg Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is an interaction between Metosartan CH 50 mg/6.25 mg/40 mg Tablet and trimethoprim, they can be taken together if prescribed by a doctor. However, consult a doctor if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, and a weak pulse. Do not discontinue the medications without consulting a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
शराब
सावधानी
मेटोसर्टन सीएच 50/6.25 मिलीग्राम टैबलेट 10 लेते समय शराब के सेवन से बचें या सीमित करें क्योंकि इससे चक्कर आना बढ़ सकता है।
गर्भावस्था
सावधानी
यदि आप गर्भवती हैं तो कृपया अपने चिकित्सक से परामर्श करें; आपका डॉक्टर तभी दवा लिखेगा जब लाभ जोखिमों से अधिक हों। गर्भावस्था के दूसरे और तीसरे तिमाही के दौरान मेटोसर्टन सीएच 50/6.25 मिलीग्राम टैबलेट 10 को बंद कर देना चाहिए क्योंकि यह विकासशील भ्रूण को प्रभावित कर सकता है।
स्तनपान
सावधानी
कृपया अपने डॉक्टर से सलाह लें; आपका डॉक्टर तय करेगा कि स्तनपान कराने वाली माताएं मेटोसर्टन सीएच 50/6.25 मिलीग्राम टैबलेट 10 ले सकती हैं या नहीं।
ड्राइविंग
सावधानी
मेटोसर्टन सीएच 50/6.25 मिलीग्राम टैबलेट 10 से चक्कर आ सकते हैं, अगर आपको चक्कर आ रहे हैं तो गाड़ी न चलाएं और न ही भारी मशीनरी चलाएं।
जिगर
सावधानी
खुराक समायोजन की आवश्यकता हो सकती है। अगर आपको लीवर की समस्या है या इससे संबंधित कोई चिंता है तो कृपया अपने डॉक्टर से सलाह लें।
गुर्दा
सावधानी
खुराक समायोजन की आवश्यकता हो सकती है। अगर आपको किडनी की समस्या है या इससे संबंधित कोई चिंता है तो कृपया अपने डॉक्टर से सलाह लें।
बच्चे
सावधानी
बच्चों के लिए मेटोसर्टन सीएच 50/6.25 मिलीग्राम टैबलेट 10 की सिफारिश नहीं की जाती है क्योंकि सुरक्षा और प्रभावशीलता स्थापित नहीं की गई है।
Customers Also Bought
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
